Giant Biogene Holding Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,519	5,539	3,524	2,364	1,552
Revenue Growth (YoY)	-0.37%	57.17%	49.05%	52.30%	30.41%
Cost of Revenue	1,085	991.9	577.01	369.21	198.15
Gross Profit	4,433	4,547	2,947	1,995	1,354
Selling, General & Admin	2,224	2,159	1,261	817.44	418.49
Research & Development	88.79	106.5	74.97	44.04	24.95
Operating Expenses	2,313	2,265	1,335	862.1	443.77
Operating Income	2,121	2,282	1,612	1,133	910.57
Interest Expense	-0.3	-0.24	-0.11	-0.02	-
Interest & Investment Income	167.68	111.35	47.49	13.16	9.41
Earnings From Equity Investments	9.5	-3.6	-	-	-
Currency Exchange Gain (Loss)	-14.97	-3.59	1.09	-14.45	21.61
Other Non Operating Income (Expenses)	17.69	28.36	55.58	54.2	16.86
EBT Excluding Unusual Items	2,300	2,414	1,716	1,186	958.44
Gain (Loss) on Sale of Investments	49.93	43.27	29.33	-8.28	14.47
Gain (Loss) on Sale of Assets	-	0.67	-	-	-
Pretax Income	2,350	2,458	1,745	1,178	972.92
Income Tax Expense	435.64	396.03	296.89	176.16	144.79
Earnings From Continuing Operations	1,915	2,062	1,448	1,002	828.13
Minority Interest in Earnings	0.17	0.62	3.55	0.44	-
Net Income	1,915	2,062	1,452	1,002	828.13
Preferred Dividends & Other Adjustments	-	-	-	306.03	19.32
Net Income to Common	1,915	2,062	1,452	696	808.81
Net Income Growth	-7.15%	42.06%	44.88%	21.00%	0.20%
Shares Outstanding (Basic)	1,047	982	976	703	975
Shares Outstanding (Diluted)	1,059	1,002	983	1,021	1,001
Shares Change (YoY)	5.76%	1.93%	-3.77%	2.03%	0.09%
EPS (Basic)	1.83	2.10	1.49	0.99	0.83
EPS (Diluted)	1.81	2.06	1.48	0.98	0.83
EPS Growth	-12.14%	39.19%	50.83%	18.70%	0.03%
Free Cash Flow	-	1,794	1,421	778.97	617.4
Free Cash Flow Per Share	-	1.79	1.45	0.76	0.62
Dividend Per Share	0.539	0.602	0.440	-	-
Dividend Growth	-10.48%	36.84%	-	-	-
Gross Margin	80.34%	82.09%	83.63%	84.39%	87.24%
Operating Margin	38.43%	41.19%	45.73%	47.92%	58.65%
Profit Margin	34.70%	37.23%	41.19%	29.44%	52.10%
Free Cash Flow Margin	-	32.40%	40.33%	32.95%	39.77%
EBITDA	2,165	2,325	1,643	1,159	933.64
EBITDA Margin	39.23%	41.98%	46.63%	49.00%	60.14%
D&A For EBITDA	43.92	43.92	31.62	25.53	23.07
EBIT	2,121	2,282	1,612	1,133	910.57
EBIT Margin	38.43%	41.19%	45.73%	47.92%	58.65%
Effective Tax Rate	18.54%	16.11%	17.01%	14.96%	14.88%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.